Joshua Daniel, MD
Neurology · Somers Point, NJNPI 1841647823
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $40,940 of the $41,999 with a category attached, or 97.5%. AbbVie accounts for 99.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $26,846 and has fallen 99.9% since, to $25 in 2024. Among neurology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $407.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$42K
- Amgen$52
- Teva Pharmaceuticals USA, Inc.$50
- Supernus Pharmaceuticals, Inc.$41
- Biohaven Pharmaceutical Holding Company Ltd.$32
- E.r. Squibb & Sons, L.L.C.$30
- plus $108 from 6 others
What the payments were for
- Speaking & faculty fees$40,94097%
- Travel & lodging$1460%
- Food & beverage$8772%
- Education$370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 81 | $41,687 |
| Amgen | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 4 | $50 |
| Supernus Pharmaceuticals, Inc. | 3 | $41 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Avanir Pharmaceuticals, Inc. | 2 | $28 |
| Biohaven Pharmaceuticals, Inc. | 2 | $27 |
| UCB, Inc. | 1 | $15 |
| SK Life Science, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
| Amneal Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$41,999 in reported general payments places this provider in the 90th percentile of 521 neurology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Somers Point
- Steven BromleyAudubon$1.5M
- Mary Ann PiconeTeaneck$1.5M
- Fiona GuptaOradell$1.1M
- Matthew DavisMiddletown$567K
- Amos KatzEatontown$558K
- Monte PellmarFreehold$429K
- Marcie RabinSummit$387K
- Ashish KapoorBayonne$329K
- Mario VukicHackensack$310K
- Andrew SylvesterBridgewater$296K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.